Results 211 to 220 of about 14,058 (258)
Some of the next articles are maybe not open access.
Water Research, 2020
Nebivolol (NEB) is widely used for the treatment of hypertension and chronic heart failure and has become an ubiquitous emerging organic pollutant.
Jieqiong Wang +3 more
semanticscholar +1 more source
Nebivolol (NEB) is widely used for the treatment of hypertension and chronic heart failure and has become an ubiquitous emerging organic pollutant.
Jieqiong Wang +3 more
semanticscholar +1 more source
Protective effects of nebivolol on ovarian ischemia–reperfusion injury in rat
The journal of obstetrics and gynaecology research, 2020Ovarian torsion is a common gynecological emergency of reproductive ages, occurring at rates of 2.7–7.4%. This study aimed to evaluate the antioxidant effects of Nebivolol (NEB) and histopathological changes in experimental ischemic (I) and ischemic ...
S. Çolak +5 more
semanticscholar +1 more source
Pharmaceutical cocrystals of nebivolol hydrochloride with enhanced solubility
, 2020Nebivolol hydrochloride is an antihypertensive BCS class II drug with low solubility and high permeability prescribed as antihypertensive. Crystal engineering was applied to prepare novel cocrystal forms of nebivolol hydrochloride with general GRAS ...
Vilas J. Nikam, S. Patil
semanticscholar +1 more source
European Review for Medical and Pharmacological Sciences, 2022
E. Said +6 more
semanticscholar +1 more source
E. Said +6 more
semanticscholar +1 more source
Journal de pharmacie de Belgique, 1992
Nebivolol is a mixture of equal amounts of two enantiomers: SR3-nebivolol (d-nebivolol) and RS3-nebivolol (l-nebivolol). SR3-nebivolol is a potent and selective beta 1-adrenergic antagonist both in vitro and in vivo. Nebivolol acutely lowers blood pressure in spontaneously hypertensive rats and induces a slight decrease in total peripheral vascular ...
openaire +2 more sources
Nebivolol is a mixture of equal amounts of two enantiomers: SR3-nebivolol (d-nebivolol) and RS3-nebivolol (l-nebivolol). SR3-nebivolol is a potent and selective beta 1-adrenergic antagonist both in vitro and in vivo. Nebivolol acutely lowers blood pressure in spontaneously hypertensive rats and induces a slight decrease in total peripheral vascular ...
openaire +2 more sources
European journal of drug metabolism and pharmacokinetics, 2022
P. Kilford +3 more
semanticscholar +1 more source
P. Kilford +3 more
semanticscholar +1 more source

